Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 607.50M
March 31, 2026 651.80M
December 31, 2025 688.10M
September 30, 2025 679.40M
June 30, 2025 694.70M
March 31, 2025 687.60M
December 31, 2024 710.30M
September 30, 2024 729.30M
June 30, 2024 739.80M
March 31, 2024 741.40M
December 31, 2023 747.00M
Date Value
September 30, 2023 749.90M
June 30, 2023 745.00M
March 31, 2023 758.40M
December 31, 2022 759.80M
September 30, 2022 774.90M
June 30, 2022 807.80M
March 31, 2022 807.50M
December 31, 2021 812.60M
September 30, 2021 608.70M
June 30, 2021 398.90M
March 31, 2021 196.30M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Artivion, Inc. 288.41M
Abbott Laboratories 24.60B
AngioDynamics, Inc. 170.32M
Alphatec Holdings, Inc. 500.18M
AtriCure, Inc. 431.62M